Navigation Links
Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation
Date:12/8/2009

nt, so we are particularly heartened to be growing our membership," says PhRMA President and CEO Billy Tauzin. "This is the result of biopharmaceutical companies -- both large and small -- seeing a tremendous opportunity to work together on important policy issues that impact patients around the world. Our primary goal is to help preserve and strengthen public policies that foster the development of new medicines -- something policymakers should consider critical if we want to develop new treatments and cures for diseases such as cancer, Parkinson's disease and heart disease."

Tauzin continued, "We are an organization committed to putting the needs of patients first. For years, PhRMA has wholeheartedly supported the notion that people do not check into the doctor's office as a Republican or Democrat, but rather as a patient. PhRMA's advocacy efforts reflect this belief and it remains to this day, a primary reason why we support public policies that encourage medical innovation in the U.S."

Today's announcement follows a recent decision by the PhRMA's Board of Directors to establish a new Committee on Small Biopharmaceutical Companies, which is composed of full and research associate members. The committee was created to address the particular issues facing these smaller specialty companies, including the impact public policies may have on such an important sector of our economy.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: '/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
2. Seven-Year Neck Pain Study Sheds Light on Best Care
3. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
4. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
5. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
11. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Mauna Kea Technologies (Euronext: MKEA, FR0010609263), inventor ... announced the set-up of an optical biopsy program at ... de Grenoble is now the first hospital in ... interventional pulmonology and urology patients an innovative platform for ... to the endomicroscopy technology developed by Mauna Kea Technologies. ...
(Date:3/31/2015)... 30, 2015 Research and Markets ( ... "Global Nuclear Imaging Market 2015-2019" report to their ... Imaging market to grow at a CAGR of 5.89 ... The report, Global Nuclear Imaging market 2015-2019, has been ... from industry experts. The report covers the Americas, and ...
(Date:3/31/2015)... DUBLIN , Mar. 27, 2015 Research and ... addition of the "Intraoperative Imaging Market by Type ... to 2019" report to their offering. ... at a CAGR of 3.5% from 2014 to 2019 ... future due to a number of forces that favor ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3Global Nuclear Imaging Market 2015-2019 with GE healthcare, Philips Healthcare & Siemens Healthcare Dominating 2Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market 2015-2019 2
... DALLAS, January 5, 2012 The " ... Billing & Coding) and Pharmaceutical (Clinical trial & Contract manufacturing) ... " analyzes and studies the major market drivers, restraints, ... and Rest of the world. Browse ...
...  The Musculoskeletal Transplant Foundation (MTF) has announced the release of ... kits. The new sizes--16cm x 20cm and 20cm x 20cm--are ... and their patients. This unique human dermal allograft is specifically ... It has been a year since MTF introduced its bi-lateral ...
Cached Medicine Technology:MarketsandMarkets: Global Healthcare BPO Market worth $330 Billion by 2016 2MarketsandMarkets: Global Healthcare BPO Market worth $330 Billion by 2016 3New, Larger, Bilateral Breast Graft Kits Announced by MTF 2
(Date:4/1/2015)... 2015 Amada Senior Care , premier ... recently opened a new office in Rocky Mount, NC – ... Lee Bissett decided to make the move to senior care ... over 20 years of experience in management and consulting. Their ... , When asked what makes Amada different from other ...
(Date:4/1/2015)... San Francisco based sustainable medical apparel manufacturer, ... Operation Smile, have launched a yearlong campaign ... RxOrganics is generously donating 5% of all purchases ... throughout 2015. RxOrganics has committed to an uncapped annual ... order placed online through the Rxmedical shop will have ...
(Date:4/1/2015)... 2015 Results are in for the ... featured 11 new homes from across the state exemplifying ... utilized innovative building techniques and new technology intended to ... Associates, Inc. (SWA) provided sustainability consulting services for 4 ... including the first- and third-place winners. , The Benker ...
(Date:4/1/2015)... Oak Brook, IL (PRWEB) April 01, 2015 ... unfortunately benefited greatly from climate change in recent years, ... will develop an allergic reaction if exposed to poison ... as outdoor enthusiasts and families prepare for summer adventures ... of an uncomfortable poison plant reaction is greater than ...
(Date:3/31/2015)... 2015 Bon Secours New York Health ... Schervier Nursing Care Center family last week. The Sisters ... in Yonkers which is scheduled to close later this ... of the Sisters of Charity of New York, the ... to place their Sisters at Schervier Nursing Care Center ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Eastern North Carolina 2Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2
... ... is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will join ENTA ... ... LLP (ENTA) is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will ...
... which is the most common vascular complication after ... graft loss and devastating consequences. Surgical techniques are ... Despite improvements in surgical techniques, arterial reconstruction in ... With atraumatic microsurgical techniques, the reconstruction of HA ...
... of N-terminal pro-B-type natriuretic peptide (NT-proBNP, a protein thought ... robust, non-invasive predictor of cardiovascular (CV) risk in patients ... the results of a multinational study presented today at ... Against Rheumatism in Rome, Italy. The presence of ...
... ... like driving, especially those parents who live in areas where public transportation is limited or ... group in Walnut Creek and San Francisco to cope with this and many other dilemmas. ... Walnut Creek, CA (PRWEB) ...
... after new rules took effect, study finds , THURSDAY, ... to doctors who administer outpatient chemotherapy drugs actually led ... finds a new study. , "This sort of dynamic ... economists often encounter this sort of thing," Joseph Newhouse, ...
... ... that it has added a brand new 2009 Cessna Grand Caravan to its fleet of modern ... (PRWEB) June 17, 2010 ... that it has added a brand new 2009 Cessna Grand Caravan to its fleet of modern ...
Cached Medicine News:Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 2Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 3Health News:NT-proBNP is a predictor of CV risk in arthritis patients taking NSAIDs 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 2Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 3Health News:Support Group for Families Dealing with When to Take the Keys Away From Dad and Other Issues 4Health News:Medicare Cuts May Have Led Docs to Prescribe More Chemo 2Health News:Talon Air Adds A Brand New Cessna Grand Caravan Turbo Prop To Its Growing Private Jet Charter Fleet 2
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: